[1]
“STUDY OF FIBROSIS PATHWAYS (TGF-Β AND WNT SIGNALING) AS THERAPEUTIC TARGETS IN CHRONIC KIDNEY DISEASE”, Multidisciplinary, Scientific Work and Management Journal, vol. 36, no. 1s, pp. 2466–2470, Apr. 2026, doi: 10.7492/6nvwdg38.